Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

Abstract

These results confirm the early and sustained efficacy of lasmiditan 100 mg and 200 mg and demonstrate consistency of response across multiple attacks.<b>Trial Registration Number:</b> NCT03670810.